KalVista Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.

About KALV

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.

CEO

Benjamin L. Palleiko

CEOBenjamin L. Palleiko

Employees

150

Employees150

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2004

Founded2004

Employees

150

Employees150

KALV Key Statistics

Market cap

566.26M

Market cap566.26M

Price-Earnings ratio

-3.06

Price-Earnings ratio-3.06

Dividend yield

—

Dividend yield—

Average volume

454.00K

Average volume454.00K

High today

—

High today—

Low today

—

Low today—

Open price

$11.22

Open price$11.22

Volume

0.00

Volume0.00

52 Week high

$15.50

52 Week high$15.50

52 Week low

$7.30

52 Week low$7.30

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own KALV. This list is generated using Robinhood data, and it’s not a recommendation.